-+ 0.00%
-+ 0.00%
-+ 0.00%
Filana Therapeutics Appoints Jill M. Quigley to Board
Share
Listen to the news
Filana Therapeutics Appoints Jill M. Quigley to Board
  • Filana Therapeutics appointed Jill M. Quigley to its board as an independent director.
  • Quigley served as CEO of Genuiti Therapeutics from September 2023 through June 2025, bringing more than 20 years of biotechnology leadership experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Filana Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611110800PRIMZONEFULLFEED9875215) on November 11, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending